Purple Finance Ltd

Direct Assignment of loan portfolio

• Finance Committee approved sale of part of loan portfolio up to Rs 5.38 crore under RBI Direction 2025.
• Direct Assignment ratio 90:10 between assignees and Purple Finance; PFL to continue as servicer.
• Transaction expected to be income accretive and support origination of quality loan portfolio.
• No change to governance; approval by Finance Committee.
• Date of approval: August 12, 2026.

Capital & MOA change

• Authorised share capital raised to Rs 97.60 crore from Rs 82.60 crore.
• Additional 1.50 crore equity shares of Rs 10 created; MOA Clause V amended.
• Clause V altered to reflect new authorised capital.
• Ordinary resolution approved for capital expansion; no promoter or director conflicts stated.
• Board authorised to perform acts needed for the change.

Section 186 investments

• Special resolution to enable investments up to Rs 200 crore in another body corporate.
• Board and KMP authorised to complete necessary filings and actions.

Preferential issue for Saksham acquisition

• Up to 1,39,99,952 equity shares issued at Rs 72 each.
• Swap: 99,99,952 shares to Saksham shareholders; cash: 40,00,000 shares to Ms. Manisha Agarwal.
• Total cash proceeds Rs 28.8 crore; balance for general corporate purposes up to 25%.
• Share swap ratio: 100 Saksham = 76 Purple shares; floor price Rs 71.40.
• Subject to ICDR rules, listing, lock-in, and approvals; promoters not subscribing noted.
• Promoters/directors are not subscribing to the offer.

Executive Director appointment

• Change designation to Whole-Time Executive Director for 3 years (Sept 1, 2026–Aug 31, 2029).
• Remuneration Rs 1.10 crore per annum; breakdown provided.
• Gratuity and ESOPs; travel expenses reimbursed; no other changes.
• Subject to applicable approval processes; other directors unaffected.

Voting & timeline

• Remote e-voting window Aug 27–30, 2026; cut-off Aug 24, 2026.
• EGM on Aug 31, 2026; VC/OAVM; speakers registered in advance.
• Scrutinizer to publish consolidated results on company website.

Impact on shareholding

• Post-issue, promoter stake expected to dilute; Annexure B outlines pre/post changes.
• Annexure B provides the pre/post shareholding patterns.

Partial redemption details

• Clarification on record date for partial NCD redemption; not an early full redemption; maturities unchanged.
• ISIN INE0CYK07020 / Scrip 977748: current FV 10,000; redeemed 1,666; post 8,333; maturity Jan 12, 2028.
• ISIN INE0CYK07012 / Scrip 977452: current FV 8,333; redeemed 1,666; post 6,666; maturity Apr 26, 2028.
• Partial redemption occurs by face-value reduction; number of NCDs remains unchanged.
• Record date for 977748 is Aug 11, 2026; payment on Aug 26, 2026.
• Record date for 977452 is Aug 28, 2026; payment by Sep 12, 2026.
• Total face-value redemption per NCD equals 10,000; schedule provided in Annexures I and II.
• Redemption schedule 07020: six installments totaling 10,000; five of 1,667, last 1,665.
• Redemption schedule 07012: six installments totaling 10,000; five of 1,667, last 1,665.
• Noted under terms of the Offer Document; update reflects partial rather than full redemption.

Meeting Details

• Date: August 06, 2026.
• Time: Not disclosed.
• Location: Corporate Office, Hallmark Business Plaza, Bandra East, Mumbai 400051.

Key Agenda Items

• Consider fund raising by issuing securities including equity, preference shares, and warrants.
• Possible modes include rights issue, QIP, preferential issue, or other permissible methods.
• Seek member approval for the proposal via Postal Ballot or Extraordinary General Meeting.
• Subject to regulatory approvals and member approval as required.

Other Notes

• Trading window will remain closed for 48 hours after conclusion of the Board Meeting.

Meeting Details

• Board meeting on July 21, 2026 at the Corporate Office of the Company; time not disclosed.

Key Agenda Items

• Unaudited financial results with Limited Review Report for quarter ended June 30, 2026.
• Fund raising via issuance of securities (equity, preference shares, warrants, debentures) subject to regulatory and shareholder approvals.

Other Notes

• Trading window remains closed till 48 hours after the meeting's outcome is declared.